StockDuty ← Dashboard Oct 30, 2026 01:11 AM ET
SignalFDA/Bio

BridgeBio signals 3 launches in next 7 months with BBP-418 November 27 PDUFA and infigratinib February 4, 2027 PDUFA

Three launches signaled with BBP-418 November 27 PDUFA and infigratinib February 4, 2027 PDUFA.

Three launches signaled with BBP-418 November 27 PDUFA and infigratinib February 4, 2027 PDUFA.
Three launches signaled with BBP-418 November 27 PDUFA and infigratinib February 4, 2027 PDUFA. — impact context not separately stored; see What changed.
Sources